Image Credit: STAT News
STAT+: A top Merck executive sees a ‘fragile’ situation at NIH, but less cause for alarm over Chinese competition
Amid ongoing uncertainty around funding for the NIH and what it could mean for U.S. innovation, a top Merck executive stressed that the agency is “a fragile thing.”